Advertisement

The role of antibiotics in the pathogenesis of Candida infections

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kligman A.M.
        Are fungus infections increasing as a result of antibiotic therapy?.
        J.A.M.A. 1952; 149: 979
        • Maibach H.I.
        • Kligman A.M.
        The biology of experimental human cutaneous moniliasis (Candida albicans).
        Arch. Dermat. 1962; 85: 233
        • Merliss R.R.
        • Hoffman A.
        Steatorrhea following the use of antibiotics.
        New England J. Med. 1951; 245: 328
        • Robinson H.M.
        Moniliasis complicating antibiotic therapy.
        Arch. Dermat. & Syph. 1954; 70: 640
        • Baum G.L.
        The significance of candida albicans in human sputum.
        New England J. Med. 1960; 263: 70
        • Kennedy C.B.
        • Henington V.M.
        • Bordelon I.
        • Snider K.
        Monilia (yeast-like) infections of the skin and mucous membrane.
        J. Lab. Med. Soc. 1954; 106: 419
        • Downing J.G.
        • Conant N.F.
        Mycotic infections.
        New England J. Med. 1945; 233: 153
        • Downing J.G.
        • Conant N.F.
        Mycotic infections.
        New England J. Med. 1945; 233: 181
        • Kostmann R.
        Moniliasis of the respiratory tract.
        Acta paediat. 1945; 32: 520
        • Winner H.I.
        • Hurley R.
        Candida Albicans.
        J. & A. Churchill Ltd, London1964 (W.1.)
        • Cross W.G.
        Oral reactions to penicillin.
        Brit. M. J. 1949; 1: 171
        • Geiger A.J.
        • Wenner H.A.
        • Axilrod H.D.
        • Durlacher S.H.
        Mycotic endocarditis and meningitis.
        Yale J. Biol. & Med. 1946; 18: 259
        • Wessler S.
        • Browne H.R.
        Candida albicans (monilia albicans) infection with blood stream invasion; report of a case with a strain clinically resistant to sulfonamide drugs and to penicillin in vitro.
        Ann. Int. Med. 1945; 22: 886
        • Campbell C.C.
        • Saslaw S.
        Enhancement of growth of certain fungi by streptomycin.
        in: Proc. Soc. Exper. Biol. & Med.70. 1949: 562
        • Foley G.E.
        • Winter Jr., W.D.
        Increased mortality following penicillin therapy of chick embryos infected with Candida albicans var. stellatoidea.
        J. Infect. Dis. 1949; 85: 268
        • Zimmerman L.E.
        Candida and aspergillus endocarditis with comments on the role of antibiotics in dissemination of fungus disease.
        Arch. Path. 1950; 50: 591
        • Bazex A.
        Moniliases compliquant les thérapeutiques antibiotiques, leur traitement par la vitamine B12.
        Presse méd. 1951; 59: 1528
        • Bedford P.D.
        Black tongue and oral penicillin.
        Brit. M. J. 1946; 2: 63
        • Behrman H.T.
        Pruritus vulvae due to Aureomycin.
        J.A.M.A. 1950; 144: 995
        • Freeman H.E.
        Robinson-contact dermatitis-silicone putty. Pigmented hairy tongue accompanying antibiotherapy.
        Arch. Dermat. & Syph. 1952; 65: 99
        • Harris H.J.
        Aureomycin and chloramphenicol in brucellosis.
        J.A.M.A. 1950; 142: 161
        • Hewitt W.L.
        • Williams Jr., B.
        Chloromycetin (chloramphenicol) in the treatment of infections.
        New England J. Med. 1950; 242: 119
        • Mangiaracine A.
        Oral moniliasis following antibiotic therapy—a warning.
        New England J. Med. 1951; 244: 655
        • Manheim S.D.
        Anorectal complications of Aureomycin, Terramycin, and Chloromycetin therapy.
        New York J. Med. 1951; 51: 2759
        • McVay Jr., L.V.
        • Sprunt D.H.
        A Study of moniliasis in Aureomycin therapy.
        in: Proc. Soc. Exper. Biol. & Med.78. 1951: 759
        • Meads M.
        • Rowe W.P.
        • Haslam N.M.
        Alterations in the bacterial flora of the throat during oral therapy with Aureomycin.
        Arch. Int. Med. 1951; 87: 533
        • Ormerod F.C.
        • Friedmann I.
        A case of moniliasis.
        Brit. M. J. 1951; 2: 1439
        • Pappenfort Jr., R.B.
        • Schnall E.S.
        Moniliasis in patients treated with Aureomycin.
        Arch. Int. Med. 1951; 88: 729
        • Reiches A.J.
        Antibiotic sensitivity and moniliasis.
        Arch. Dermat. & Syph. 1951; 64: 604
        • Rossier von P.H.
        Antibiotica und Mykosen.
        Helvet med. acta. 1952; 19: 261
        • Williams Jr., B.
        Oral and pharyngeal complications of chloramphenicol (Chloromycetin) therapy.
        Am. Pract. & Digest Treat. 1950; 1: 897
        • Woods J.W.
        • Manning Jr., I.H.
        • Patterson C.N.
        Monilial infections complicating the therapeutic use of antibiotics.
        J.A.M.A. 1951; 145: 207
        • Barach A.L.
        • Bickerman H.A.
        • Beck G.J.
        Antibiotic therapy in infections of the respiratory tract.
        Arch. Int. Med. 1952; 90: 808
        • Moore M.
        In vivo and in vitro effect of Aureomycin hydrochloride on syringospora (Monilia, Candida) albicans.
        J. Lab. & Clin. Med. 1951; 37: 703
        • Smith D.T.
        The disturbance of the normal bacterial ecology by the administration of antibiotics with the development of new clinical syndromes.
        Ann. Int. Med. 1952; 37: 1135
        • Wolff F.W.
        Moniliasis pneumonia following Aureomycin therapy.
        Lancet. 1952; 1: 1237
        • Kunstadter R.H.
        • Maclean H.
        • Greengard J.
        Mycotic endocarditis due to candida albicans.
        J.A.M.A. 1952; 149: 829
        • Wybel R.E.
        Mycosis of cervical spinal cord following intrathecal penicillin therapy.
        Arch. Path. 1952; 53: 167
        • Taylor H.
        • Rundle J.A.
        Acute moniliasis of the urinary tract.
        Lancet. 1952; 1: 1236
        • Gausewitz P.L.
        • Jones F.S.
        • Worley Jr., G.
        Fatal generalized moniliasis.
        Am. J. Clin. Path. 1951; 21: 41
        • Grekin R.H.
        • Cawley E.P.
        • Zheutlin B.
        Generalized aspergillosis.
        Arch. Path. 1950; 49: 387
        • Vanbreuseghem R.
        • Balsacq J.
        • Bertrand
        Moniliase généralisée par Candida albicans chez un' enfant indigene au Congo Belge apres un traitement par les antibiotiques.
        Ann. Soc. belge méd., trop. 1952; 32: 513
        • Lipnik M.J.
        • Kligman A.M.
        • Strauss R.
        Antibiotics and fungous infections.
        J. Invest. Dermat. 1952; 18: 247
        • Munoz J.
        • Geister R.
        Inhibition of phagocytosis by Aureomycin.
        in: Proc. Soc. Exper. Biol. & Med.75. 1950: 367
        • Paine Jr., T.F.
        In vitro experiments with monilia and Escherichia coli to moniliasis in patients receiving antibiotics.
        Antibiotics & Chemother. 1952; 2: 653
        • Seligmann E.
        Virulence enhancing activities of aureornycin on Candida albicans.
        in: Proc. Soc. Exper. Biol. & Med.79. 1952: 481
        • Seligmann E.
        Virulence enhancement of Candida albicans by antibiotics and cortisone.
        in: Proc. Soc. Exper. Biol. & Med.83. 1953: 778
        • Finland M.
        • Weinstein L.
        Complications induced by antimicrobial agents.
        New England J. Med. 1953; 248: 220
        • Hutchison M.K.
        Moniliasis: a complication of antibiotic therapy.
        J. Kansas M. Soc. 1953; 54: 436
        • Wegmann Von T.
        Pilzerkrankuńgen der inneren Organe als Folge von Behandlung mit Anti-biotica, unter besonderer Berücksichtigung des Respirationstraktes. Antibiotica et Chemotherapia, Fortschr. I.
        in: S. Karger, Basel/New York1954: 235
        • Rhoads P.S.
        Hazards of antibiotic therapy.
        Arch. Int. Med. 1952; 90: 731
      1. Editorial. Super-infections during antibiotic treatment.
        Brit. M. J. 1952; 1: 537
      2. Editorial. Moniliasis.
        Lancet. 1952; 1: 1247
      3. Vaginal discharge.
        J.A.M.A. 1954; 156 (Editorial): 991
        • Stormont R.T.
        Council on pharmacy and chemistry. Warning statement to be included in Aureomycin hydrochloride, chloramphenicol and Terramycin hydrochloride, labeling.
        J.A.M.A. 1951; 145: 1267
        • Andriole V.T.
        • Kravetz H.M.
        • Roberts W.C.
        • Utz J.P.
        Candida endocarditis.
        Am. J. Med. 1962; 32: 251
        • Cannon P.R.
        The changing pathologic picture of infection since the introduction of chemotherapy and antibiotics.
        Bull. New York Acad. Med. 1955; 31: 87
        • Dobias B.
        Moniliasis in pediatrics.
        Am. J. Dis. Child. 1957; 94: 234
        • Debre R.
        • Mozziconacci P.
        • Drouhet E.
        • Drouhet V.
        • Hoppeler A.
        Les infections à Candida chez le nourrisson.
        Ann. paediat. 1955; 184: 129
      4. De Graciansky P. Delaporte J. Accidents a Lévures des Traitements Par Les Antibiotiques. Masson et Cie, Paris1956
        • Drouhet E.
        Antifongiques et therapeutique des mycoses.
        Semaine hôp. Paris. 1957; 33: 843
        • Drouhet E.
        • Vieu M.
        Biologie des infections à Candida. I. Diagnostic de laboratoire. (Étude de 342 souches de: Candida isolées de prélévements pathologiques).
        Semaine hôp. Paris. 1957; 33: 793
        • Drouhet E.
        Biologie des infections à Candida. II. Sur les manifestations pathologiques et les conditions étiologiquès et pathogéniques de 175 cas de candidose.
        Semaine hôp. Paris. 1957; 33: 807
        • Drouhet M.E.
        Quelques aspects mycologiques, pathogéniques et thérapeutiques des candidoses.
        Bull. Soc. franc. dermat. et syph. 1960; 67: 646
        • Lutz A.
        • Grootten O.
        • Witz M.A.
        Étude sur des champignons levuriformes du genre Candida-leur fréquence-l'action de la Mycostatine et de la Trichomycine.
        Rev. d'immunol. 1957; 21: 237
        • Giunchi G.
        Candidosis following antibiotic therapy.
        Sc. med. ital. 1958; 6: 580
        • Kashkin P.N.
        • Krassilnicov N.A.
        • Nekachalov V.Y.
        Candida complications after antibiotic therapy.
        Mycopath. et mycol. appl. 1961; 14: 173
        • Awachat A.K.
        Candidiasis.
        Antiseptic. 1961; 58: 43
        • Donomae I.
        • Kawamori Y.
        Moniliasis.
        J. Antibiotics. 1955; 8 (s. A and B): 171
        • Donomae I.
        Panel discussion on candidiasis.
        J. Antibiotics. 1958; 11 (s.A., supp.:): 62
        • Donomae I.
        • Takahashi H.
        • Tsubura E.I.
        Incidence of candidiasis in Japan deep-seated candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 1
        • Sternberg T.H.
        • Newcomer V.D.
        Therapy of fungus diseases. An international symposium. Little, Brown & Co, Boston1955
        • Keye Jr., J.D.
        • Magee W.E.
        Fungal diseases in a general hospital. A study of 88 patients.
        Am. J. Clin. Path. 1956; 26: 1235
        • Torack R.M.
        Fungus infections associated with antibiotic and steroid therapy.
        Am. J. Med. 1957; 22: 872
        • Baker R.D.
        Leukopenia and therapy in leukemia as factors predisposing to fatal mycoses.
        Am. J. Clin. Path. 1962; 37: 358
        • Gruhn J.G.
        • Sanson J.
        Mycotic infections in leukemic patients at autopsy.
        Cancer. 1963; 16: 61
        • Carpenter A.M.
        Studies on candida. I. Identification of 100 yeast-like fungi isolated from children.
        Am. J. Clin. Path. 1955; 25: 98
        • Gerloczy F.
        • Schmidt K.
        • Scholz M.
        Beiträge zur Frage der Moniliasis im Säuglingsalter.
        Ann. Pediat. 1956; 187: 119
        • Goto T.
        Studies on candidiasis in the oral and the oto-laryngological aspect.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 183
        • Hildick-Smith G.
        • Blank H.
        • Sarkany I.
        Fungus diseases and their treatment.
        J. & A. Churchill Ltd, London1964
        • Dearing W.H.
        • Heilman F.R.
        The effect of Aureomycin on the bacterial flora of the intestinal tract of man: a contribution to preoperative preparation.
        in: Proc. Staff Meet. Mayo Clin.25. 1950: 87
        • Loh W.P.
        • Baker E.E.
        Fecal flora of man after oral administration of chlortetracycline or oxytetracycline.
        Arch. Int. Med. 1955; 95: 74
        • Carter J.J.
        • Covert S.V.
        • Eckert C.
        Nystatin in the control of fungous overgrowth during large bowel chemotherapy.
        Arch. Surg. 1960; 80: 541
        • Cox Jr., R.S.
        • Hannon J.L.
        An evaluation of neomycin plus nystatin as a monilial suppressant in preoperative bowel preparation.
        Antibiotics Ann. 1957–1958; : 658
        • Spaulding E.H.
        • Tyson R.R.
        • Harris M.J.
        • Jacobs B.
        • Wildrick L.
        • Johnson K.O.
        Further studies on intestinal antisepsis: neomycin-nystatin.
        Antibiotics Ann. 1956–1957; : 236
        • Spaulding E.H.
        • Rao N.U.
        • Tyson R.R.
        • Zubrzycki L.
        • Harris M.J.
        Antifungal action of nystatin on, the fecal flora during administration of neomycin-polymyxih.
        Antibiotics Ann. 1955–1956; : 681
        • Meleney F.L.
        • Johnson B.A.
        Alimentary tract antisepsis with oral bacitracin and neomycin.
        Antibiotics Ann. 1956–1957; : 244
        • Reiersol S.
        Occurrence of yeasts in the intestinal tract of 20 patients during treatment with bacitracin and neomycin. Antonie v. Leeuwenhoek.
        J. Microbiol. & Serol. 1958; 24: 23
        • Spaulding E.H.
        • Tyson R.R.
        The role of nystatin in intestinal antisepsis.
        Monogr. Ther. 1957; 2: 38
        • Cohn Jr., I.
        • Longacre A.B.
        Preoperative sterilization of the colon. Comparison of various antibacterial agents.
        in: Welch H. Marti-Ibañez F. Antibiotics Annual, 1955–1956. Medical Encyclopedia, Inc, New York1956: 105
        • Cohn Jr., I.
        • Longacre A.B.
        Preoperative sterilization of the colon. Comparison of various antibacterial agents. II.
        Antibiotics Ann. 1956–1957; : 253
        • Cohn Jr., I.
        • Longacre A.B.
        Preoperative sterilization of the colon. Comparison of various antibacterial agents. IV.
        Antibiotics Ann. 1958–1959; : 761
        • Cohn Jr., I.
        Yeast growth during preoperative preparation of the colon with antibiotics.
        Monogr. Ther. 1957; 2: 43
        • Andreassen M.
        • Eriksen K.R.
        • Stenderup A.
        Monilial peritonitis as a complication of preoperative intestinal sterilisation.
        Lancet. 1958; 2: 618
        • Ishiyama S.
        Nystatin and gastrointestinal candidase.
        J. Antibiotics. 1958; 11 (s.A, supp.:): 17
        • Reynell P.C.
        • Martin E.A.
        • Beard A.W.
        Monilia peritonitis.
        Brit. M. J. 1953; 1: 919
        • Braude A.I.
        • Rock J.A.
        The syndrome of acute disseminated moniliasis in adults.
        Arch. Int. Med. 1959; 104: 91
        • Conn N.K.
        • Crean G.P.
        • Maccabe A.F.
        Systemic candidiasis and endocarditis due to C. tropicalis.
        Brit. M. J. 1959; 1: 944
        • Louria D.B.
        • Dineen P.
        Amphotericin B in treatment of disseminated moniliasis.
        J.A.M.A. 1960; 174: 273
        • Matthias J.Q.
        • Rees E.G.
        Candida septicemia complicating antibiotic therapy.
        J. Path. Bact. 1956; 71: 512
        • Richet G.
        • Drouhet E.
        • Ducrot H.
        • Jungers P.
        Guérison de deux cas de septicémie à Candida albicans compliquant une anurie grave. Action de l'amphotéricine.
        Bull. et mém. Soc. m'ed. hôp. Paris. 1959; 75: 780
        • Vergez J.
        • Simon R.
        Pyonéphrose à “Monilia albicans.”.
        Mém. Acad. Chir. 1953; 79: 422
        • Akiba T.
        • Iwata K.
        • Inoue S.
        Studies on the serologic diagnosis of candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 65
        • McGovern J.J.
        • Parrott R.H.
        • Emmons C.W.
        • Ross S.
        • Burke F.G.
        • Rice E.C.
        The effect of Aureomycin and chloramphenicol on the fungal and bacterial flora of children.
        New England J. Med. 1953; 248: 397
        • Garrahan J.P.
        • Sampayo R.L.
        • Meroni R.J.
        • Landivar R.O.
        • Masanti J.G.
        Accion de los antibioticos y quimioterapicos sobre la incidencia del genero candida en el tracto gastrointestinal. Efectos de la nistatina.
        Res. Asoc. méd. argent. 1957; 71: 27
        • Sharp J.L.
        The growth of Candida albicans during antibiotic therapy.
        Lancet. 1954; 1: 390
        • Newcomer V.D.
        • Wright E.T.
        • Sternberg T.H.
        The effect of nystatin when administered simultaneously with tetracycline upon the yeast flora of the gastrointestinal tract of man.
        Antibiotics Ann. 1954–1955; : 686
        • Sternberg T.H.
        • Tarbet J.E.
        • Newcomer V.D.
        • Huddleson H.G.
        • Weir R.H.
        • Wright E.T.
        • Egeberg R.O.
        Antifungal effects of nystatin on the fecal flora of animals and man.
        Antibiotics Ann. 1953–1954; : 199
        • Bartels H.A.
        Monilial infection of the mouth following antibiotic therapy.
        Oral Surg. 1953; 7: 790
        • Bartels H.A.
        • Buchbinder M.
        Yeastlike microorganisms isolated from root canals.
        Oral Surg. 1954; 7: 98
        • Mountain D.C.
        Oral uudecylinic acid in the prevention of the so-called monilial complications secondary to the use of Aureomycin, Chloramphenicol and Terramycin.
        Am. J. M. Sc. 1953; 225: 274
        • Weinstein L.
        • Goldfield M.
        • Chang T.W.
        Infections occurring during chemotherapy. A study of their frequency, type and predisposing factors.
        New England J. Med. 1954; 251: 247
        • Childs A.J.
        Effect of nystatin on growth of Candida albicans during antibiotic therapy.
        Brit. M. J. 1956; 1: 660
        • Childs A.J.
        Further clinical trials of amphotericin.
        Scottish. M. J. 1959; 4: 80
        • From P.
        • Alli J.H.
        Clinical, bacteriological, and mycological evaluation of tetracyclinenystatin (Mysteclin) in pulmonary disease.
        Antibiotic Med. & Clin. Ther. 1958; 5: 639
        • Fuji R.
        • Ichihashi H.
        • Minamitani M.
        • Morota S.
        • Hoshiyama K.
        • Takiguchi F.
        • Ishibashi T.
        Studies on the Candida infections in childhood.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 40
        • Halde C.
        • Wright E.T.
        • Pollard II, W.H.
        • Newcomer V.D.
        • Sternberg T.H.
        The effect of amphotericin B upon the yeast flora of the gastrointestinal tract of man.
        Antibiotics Ann. 1956–1957; : 123
        • Hewitt W.L.
        • Finegold S.M.
        • Sutter V.L.
        Incidence of side effects and changes in fecal microflora following administration of tetracycline and tetracycline-nystatin.
        Antibiotics Ann. 1955–1956; : 856
        • Kozinn P.J.
        • Burchall J.J.
        • Taschdjian C.L.
        Clinical trial of tetracyclirie-amphotericin B in pediatric patients.
        Squibb Clin. Res. Notes. 1960; 3: 3
        • Kozinn P.J.
        • Burchall J.J.
        • Katz A.
        • Taschdjian C.L.
        Clinical trial of an amphotericin B-tetracycline combination in pediatric patients.
        Antibiotic Med. & Clin. Ther. 1960; 7: 749
        • Larkin R.
        Side-effects of tetracycline alone and of tetracycline with nystatin.
        Lancet. 1959; 1: 1228
        • Lepper M.H.
        • Pearson J.Z.
        A study of the effect of tetracycline plus nystatin on aerobic fecal flora as compared to tetracycline alone.
        Antibiotics Ann. 1956–1957; : 221
        • Metzger W.L.
        • Steigmann F.
        • Jenkins Jr., C.J.
        • Pamukcu S.F.
        • Kaminski L.
        Comparative effects of tetracycline alone and in combination with nystatin on the intestinal flora of man.
        Antibiotics Ann. 1956–1957; : 208
        • Range G.L.
        • Oriatti M.D.
        • Engbring G.M.
        Therapeutic results and changes in fecal flora relative to side effects of tetracycline-nystatin.
        Antibiotics Ann. 1956–1957; : 216
        • Reichelderfer T.E.
        Tetracycline-amphotericin B in pediatric practice, preliminary evaluation.
        Antibiotic Med. & Clin. Ther. 1960; 7: 541
        • Sklar E.M.
        Proliferation of yeast-like fungi during oral antibiotic therapy.
        M. Press. 1961; 245: 227
        • Uchimura R.
        • Nakazawa S.
        • Numao K.
        • Ogawa G.
        Clinical treatment with nystatin.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 32
        • Younger D.
        • Epifano L.D.
        • DiPillo F.
        • Hoffman I.
        • Thaler E.
        • Yarvis M.
        A clinical comparison of the side effects of tetracyclinenystatin and tetracycline.
        Antibiotic Med. & Chemother. 1959; 6: 216
        • Baden W.E.
        Staphylococcal and subsequent Candida albicans enterocolitis complicating novobiocin therapy.
        Am. J. Obst. & Gynec. 1957; 74: 47
        • Blank H.
        Antifungal antibiotics in clinical medicine.
        Arch. Dermat. & Syph. 1957; 75: 184
        • Blank H.
        Candida albicans. Frequent companion, occasional foe.
        Monogr. Ther. 1957; 2: 1
        • Drouhet E.
        Therapeutic activity on nystatin (Mycostatin) in Candida infections.
        in: Sternberg T.H. Newcomer V.D Therapy of Fungus Diseases. An International Symposium. Little, Brown & Co, Boston, Toronto1955: 211
        • Garbulsky M.
        • Yarsky R.
        Niveles plasmaticos de tetraciclina despues de la administracion oral de tres preparados diferentes. Clorhidrato de oxitetraciclina, clorhidrato de tetraciclina y complejo de fosfato de tetraciclina.
        Med. Panamericana. 1960; 14: 283
        • Huang N.N.
        • Sarria A.
        • High R.H.
        Therapeutic evaluation of nystatin and amphotericin in oral moniliasis in infants and children.
        Antibiotics Ann. 1957–1958; : 59
        • Iacapraro G.
        Una nueva sal de tetraciclina: fosfato de tetraciclina. Estudio preliminar.
        Semana méd. 1958; 112 (Jan. 9): 54
        • Iacapraro G.
        Observaciones clinicas con la asociacion complejb de fosfato de tetraciclina-nistatina.
        Semana méd. 1958; 112: 171-178
        • Kitamura K.
        • Fukushiro R.
        • Kagawa S.
        • Nishiyama S.
        • Takahashi H.
        Black hairy tongue.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 156
        • Koyama Y.
        • Koya G.
        • Kosakai N.
        • Yano N.
        Incidence of Candida contamination in oral cavity among hospital patients and the treatment of upper respiratory candidiasis with nystatin.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 25
        • Kozinn P.J.
        • Taschdjian C.L.
        Oral thrush treated with lyophilized nystatin.
        Antibiotics Ann. 1957–1958; : 75
        • Kozinn P.J.
        • Taschdjian C.L.
        • Dragutsky D.
        • Minsky A.
        Therapy of oral thrush: a comparative evaluation of gentian violet, mycostatin, and amphotericin B.
        Monogr. Ther. 1957; 2: 16
        • Lepper M.H.
        The use of nystatin in the control of candidiasis, particularly that following the use of antibacterial agents.
        Monogr. Ther. 1957; 2: 7
        • Quinn L.Y.
        • Wilbur R.D.
        • Catron D.V.
        In vitro response of Candida albicans and Candida tropicalis to antifungal agents.
        Antibiotics & Chemother. 1960; 10: 95
        • Reichert J.
        Pruritus ani and antibiotics.
        Am. J. Proctol. 1955; 6: 57
        • Robinson M.M.
        Treatment of acne vulgaris with tetracycline-nystatin and tetracycline.
        Antibiotics Ann. 1957–1958; : 451
        • Sappington T.S.
        • McCarten W.G.
        • Clarence L.H.
        Diarrhea and Candida albicans infestation of the colon.
        M. Ann. District of Columbia. 1963; 32: 48
        • Stewart G.T.
        Laboratory and clinical studies with nystatin in post-antibiotic mycotic infections.
        Brit. M. J. 1956; 1: 658
        • Stough A.H.
        • Groel J.T.
        • Kroeger W.H.
        Efficacy of amphotericin in controlling Candida albicans in patients treated with tetracycline.
        Squibb Clin. Res. Notes. 1960; 3: 8
        • Trafton H.M.
        • Lind H.E.
        Use of a combined formulation of tetracycline phosphate complex and amphotericin B in therapy of urinary tract: infections.
        Current Therap. Res. 1961; 3: 59
        • Trafton H.M.
        • Lind H.E.
        Tetracycline phosphate complex and amphotericin B in the treatment of urinary tract infections.
        Antimicrobial Agents Ann. 1960. 1961; : 543
        • Dowling H.F.
        Council on drugs. Mixtures of antibiotics.
        J.A.M.A. 1957; 164: 44
        • Barlow A.J.E.
        Candidiasis.
        Brit. J. Dermat. 1960; 72: 419
        • Drummond M.
        Clinical and therapeutic aspects of Candida albicans.
        Irish J. M. Sc. 1956; 6: 415
        • Kozinn P.J.
        • Taschdjian C.L.
        Enteric candidiasis. Diagnosis and clinical considerations.
        Pediatrics. 1962; 30: 71
        • Lederer H.
        • Todd R.M.
        Thrush in infancy.
        Arch. Dis. Childhood. 1949; 24: 200
        • Brabander J.O.W.
        • Blank F.
        • Butas C.A.
        Intestinal moniliasis in adults.
        J. Canad. M. A. 1957; 77: 478
        • Taschdjian C.L.
        • Kozinn P.J.
        Laboratory and clinical studies on candidiasis in the new-born infant.
        J. Pediat. 1957; 50: 426
        • Kozinn P.J.
        • Taschdjian C.L.
        Oral moniliasis.
        New England J. Med. 1962; 266: 208
        • Beemer A.M.
        • Pryce D.M.
        • Riddell R.W.
        Candida albicans infection of the gut.
        J. Path. & Bact. 1954; 68: 359
        • De Gavaller B.
        Moniliasis en los recien nacidos.
        Res. obstet. y ginec. 1953; 13: 203
        • Lelong M.
        • Alison F.
        • Vinh L.T.
        • Van Ty D.
        • Desmonts G.
        • Cabanes J.
        Le muguet généralisé (septicémie à Candida albicans).
        Ann. méd. 1953; 54: 5
        • Stein A.A.
        Systemic moniliasis: a clinicopathological report of five cases.
        Antibiotic Med. 1959; 6: 297
        • Craig J.M.
        • Farber S.
        The development of disseminated visceral mycosis during therapy for acute leukemia.
        Am. J. Path. 1953; 29: 601
        • Dobias B.
        Treatment of cutaneous moniliasis in pediatrics with nystatin.
        Monogr. Therapy. 1957; 2: 49
        • Harrell E.R.
        • Thompson G.R.
        Systemic candidiasis (moniliasis) complicating treatment of bacterial endocarditis, with review of literature and report of apparent cure of one case with parenteral mycostatin.
        Ann. Int. Med. 1958; 49: 207
        • Louria D.B.
        • Stiff D.P.
        • Bennett B.
        Disseminated moniliasis in the adult.
        Medicine. 1962; 41: 307
        • Vince S.
        The spread of Candida in infants and children.
        M. J. Australia. 1959; 46: 143
        • Vince S.
        Generalized endogenous mycosis in childhood.
        M. J. Australia. 1959; 46: 145
        • Zimmerman L.E.
        Fatal fungus infections complicating other diseases.
        Am. J. Clin. Path. 1955; 25: 46
        • Lee A.F.
        • Keifer W.S.
        Vaginal discharge.
        Northwest Med. 1954; 53: 1227
        • Pace H.R.
        • Schantz S.I.
        The changing incidence of monilial (Candida albicans) vaginitis.
        Monogr. Ther. 1957; 2: 29
        • Carter B.
        • Jones C.P.
        • Creadick R.N.
        • Parker R.T.
        • Turner V.
        The vaginal fungi.
        Ann. New York Acad. Sc. 1959; 83: 265
        • Hesseltine H.C.
        Biologic and clinical import of vulvo-vaginal mycoses.
        Am. J. Obst. & Gynec. 1937; 34: 855
        • Hesseltine H.C.
        Factors relating to mycotic and trichomonal infections.
        Ann. New York Acad. Sc. 1959; 83: 245
        • Plass E.D.
        • Hesseltine H.C.
        • Borts I.H.
        Monilia vulvo-vaginitis.
        Am. J. Obst. & Gynec. 1931; 21: 320
        • Gardner H.L.
        Vaginal thrush.
        Texas State J. Med. 1944; 40: 333
        • Yaffee H.S.
        • Grots I.
        Moniliasis due to norethynodrel with mestranol.
        New England J. Med. 1965; 272: 647
        • Grasset J.
        • Seneze J.
        • Gauthier R.
        Contribution a l'étude des mycoses vulvo-vaginales.
        Bull. féd. soc. gynéc. et obst. 1954; 6: 181
        • Pundel J.P.
        • Ost E.
        Mycoses vulvo-vaginales et antibiotiques.
        Bull. féd. soc, gynéc. & obst. 1954; 6: 170
        • Gaudefroy M.
        • Viart P.
        Influence des antibiotiques sur la recrudescence actuelle des vaginites mycosiques.
        Ann. Biol. Clin. 1955; 13: 113
        • Waisman M.
        Genital moniliasis as a conjugal infection.
        Arch. Dermat. & Syph. 1954; 70: 718
        • Barr CXIII, W.
        Nystatin.
        Practitioner. 1957; 178: 616
        • Notake Y.
        • Taya M.
        • Sasaki H.
        Candidiasis in obstetrics and gynecology.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 9
        • Fujimori H.
        • Takeda H.
        • Tomita T.
        Clinical experience of nystatin for gynecological candidiasis.
        J. Antibiotics. 1958; 11 (S.A. supp.:): 13
        • Mizuno S.
        Vulvo-vaginal candidiasis. Survey of vulvovaginal candidiasis in Japan.
        in: Studies of Candidiasis in Japan. Research Committee of Candidiasis, Japan1961: 19
        • Mizuno S.
        • Yoshimoto S.
        • Nagamine T.
        • Kinoue Y.
        Therapeutic effect of nystatin in vaginal and vulvar candidiasis.
        J. Antibiotics. 1958; 11 (s.A. supp.:): 14
        • Woodruff P.W.
        • Hesseltine H.C.
        Relationship of oral thrush to vaginal mycosis and incidence of each.
        Am. J. Obst. & Gynec. 1938; 36: 467
        • Pace H.R.
        • Schantz S.I.
        The changing incidence of monilial (Candida albicans) vaginitis.
        Monogr. Ther. 1957; 2 (Cited in [170].): 29
        • Bret J.
        • Coupe C.
        Vaginites et infection neonatale. Etiologie des mycoses du nouveauné.
        Presse méd. 1958; 66: 937
        • Kozinn P.J.
        • Taschdjian C.L.
        • Wiener H.
        • Dragutsky D.
        • Minsky A.
        Neonatal candidiasis.
        Pediat. Clin. North America. 1958; 5: 803
        • Swift S.
        Diaper dermatitis.
        Pediat. Clin. North America. 1956; 3: 759
        • Willi H.
        Generalisierte Moniliase der Haut bei einem Neugeborenen.
        Schweiz. med. Wchnschr. 1961; 91: 376
        • Larroche J.-Cl.
        Candidose pulmonaire chez des prematures. Discussion de leur origine foetale.
        Sem. hôp. Paris. 1957; 33: 829
        • Herpay Z.
        Die Lungenmykose Neugeborener.
        Mykosen. 1959; 2: 97
        • Robinson R.C.V.
        Nystatin in the treatment of cutaneous moniliasis.
        Monogr. Ther. 1957; 2: 55
        • Duncan A.G.
        Cutaneous moniliasis.
        Arch. Dermat. 1957; 76: 434
        • Higuchi K.
        • Urabe H.
        • Toshitani S.
        Dermatological candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 12
        • Sulzberger M.B.
        • Baer R.L.
        Some recent advances in dermatologie mycology. Tinea pedis: Trichophyton rubrum infections; Tinea capitis; moniliasis.
        in: Yearbook of Dermatology & Syphilis. 1954–1955. The Yearbook Publishers, Chicago1955: 7
        • Wright E.T.
        • Newcomer V.D.
        • Halde C.
        • Sternberg T.H.
        The use of nystatin for the treatment of candidiasis of the skin and mucous membranes.
        Monogr. Ther. 1957; 2: 12
        • Kubo I.
        • Hori M.
        • Niitani H.
        • Yokoyama I.
        • Takemoto T.
        Studies on the pathogenesis of candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 145
        • Nityanada K.
        Monilial granuloma.
        Brit. M. J. 1959; : 690
        • Robinson R.C.V.
        Cutaneous moniliasis in infants.
        J. Pediat. 1957; 50: 721
        • Bound J.P.
        Thrush napkin rashes.
        Brit. M. J. 1956; 1: 782
        • Hill L.W.
        The treatment of eczema in infants and children. II.
        J. Pediat. 1955; 47: 357
        • Cabaniss Jr., W.H.
        • Manley W.F.
        • Swan R.E.
        Cutaneous moniliasis in a premature infant. Report of a case with unusual clinical manifestations.
        J. Pediat. 1957; 50: 480
        • Mayer J.B.
        • Gotz H.
        • Seitz G.
        Eine Epidemie von Soormykose der Körperhaut unter dem Bilde der Erythrodermia desquamativa (Leiner).
        Ann. Paediat. 1951; 177: 213
      5. (b) Seelig, M. S. Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunologic defenses. Bacteriol. Rev., to be published.

        • Winner H.I.
        A study of Candida albicans agglutinins in human sera.
        J. Hyg. 1955; 53: 509
        • Rimbaud Mm.P.
        • Rioux J.A.
        • Bastide J.M.
        Les phénomènes immunologiques dans les candidoses: les réactions sérologiques.
        Bull. Soc. franç. dermat. & syph. 1960; 67: 673
        • Brody J.I.
        • Finch S.C.
        Candida-reacting antibody in the serum of patients with lymphomas and related disorders.
        Blood. 1960; 15: 830
        • Roth Jr., F.J.
        • Boyd C.C.
        • Sagami S.
        • Blank H.
        An evaluation of the fungistatic activity of serum.
        J. Invest. Dermat. 1959; 32: 549
        • Roth Jr., F.J.
        • Goldstein M.I.
        Inhibition of growth of pathogenic yeasts by human serum.
        J. Invest. Dermat. 1961; 36: 383
        • Louria D.B.
        • Brayton R.G.
        A substance in blood lethal for Candida albicans.
        Nature. 1964; 201: 309
        • Louria D.B.
        • Fallon N.
        • Browne H.G.
        The influence of cortisone on experimental fungus infections in mice.
        J. Clin. Invest. 1960; 39: 1435
        • Gresham G.A.
        • Burns M.
        Tissue invasion by Candida.
        in: Progress in Biological Science in Relation to Dermatology. Cambridge University Press, London1960: 174
        • Masshoff W.
        • Adam W.
        Histomorphologie der experimentellen, Candida-Infektion.
        Arch. klin. Exper. Dermat. 1957; 204: 416
        • Adriano S.M.
        • Schwartz J.
        Experimental moniliasis in mice.
        Am. J. Path. 1955; 31: 859
        • Donomae I.
        • Tsubura E.
        • Kuroda M.
        • Takahashi H.
        Experimental studies on treatment of candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 122
        • Winner H.I.
        Experimental moniliasis in the guinea-pig.
        J. Path. & Bact. 1960; 79: 420
        • Hazen E.L.
        • Brown R.
        • Mason A.
        Protective action of fungicidin (nystatin) in mice against virulence enhancing activity of oxytetracycline on Candida albicans.
        Antibiotics & Chemother. 1953; 3: 1125
        • Dukes C.D.
        • Tettenbaum I.S.
        Studies on the potentiation of monilial and staphylococcal infections by tetracycline.
        Antibiotics Ann. 1954–1955; : 674
        • Roth Jr., F.J.
        • Eylar O.R.
        A selective enhancement by Aureomycin of the pathogenicity of Candida albicans for mice.
        in: Bact. Proc.1954: 87
        • DeMello G.C.
        • Kiser J.S.
        The effect of several chemical compounds on experimental infections with Candida albicans.
        Antibiotics Ann. 1954–1955; : 678
        • Pinkerton M.E.
        • Patterson M.
        The effect of some selected antibiotics on experimental candidiasis.
        Texas Rep. Biol. & Med. 1957; 15: 50
        • Winter Jr., W.D.
        • Foley G.E.
        Enhancement of Candida infection; differential distribution of renal lesions in mice treated with Aureomycin.
        J. Infect. Dis. 1956; 98: 150
        • Henry B.
        • Fahlberg W.J.
        The potentiating effect of hydrocortisone acetate and tetracycline on monilial infection in mice.
        Antibiotics & Chemother. 1960; 10: 114
        • Blue M.L.
        Generalized moniliasis following prolonged antimicrobial therapy.
        Sinai Hosp. J. 1960; 9: 65
        • Brown Jr., C.
        • Propp S.
        • Guest C.M.
        • Beebe R.T.
        • Early L.
        Fatal fungus infections complicating antibiotic therapy.
        J.A.M.A. 1953; 152: 206
        • Connett M.C.
        Fatal septic thrombophlebitis due to Candida albicans after prolonged antibiotic therapy.
        Arch. Surg. 1960; 81: 726
        • Richart R.
        • Dammin G.J.
        Candida tropicalis as a pathogen for man.
        New England J. Med. 1960; 263: 474
        • Ballowitz Von L.
        • Schafer H.
        Das Auftreten von Mykosen bei antibiotischer Behandlung im Kindesalter.
        Monatsschr. Kinderh. 1954; 102: 336
        • Broz O.
        • Kopriva K.
        A case of moniliasis in an infant with rare affection of the heart and pleura.
        Pediatrics. 1953; 8: 211
        • Dobias B.
        Moniliasis in pediatrics.
        Am. J. Dis. Child. 1957; 94 (Cited in [58].): 234
        • Hradcova L.
        Thrush enterocolitis of premature infants as a complication of antibiotic treatment.
        Pediatricke listy. 1954; 9: 345
        • Dobias B.
        Moniliasis in pediatrics.
        Am. J. Dis. Child. 1957; 94 (Cited in [58].): 234
        • Schmorl G.
        Ein Fall von Soormetastase in der Niere.
        Zentralbl: Bakt. 1890; 7: 329
        • Dobias B.
        Moniliasis in pediatrics.
        Am. J. Dis. Child. 1957; 94 (Cited in [58].): 234
        • Miyake M.
        • Okudaira M.
        Recently observed five autopsy cases of Candidiasis especially with references to our statistical and immuno-pathological investigations.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 35
        • Bendel Jr., W.L.
        • Race G.J.
        Acute disseminated Candidiasis in aplastic anemia.
        Arch. Int. Med. 1961; 108: 916
        • Chapman M.G.
        Fatal disseminated moniliasis during prolonged antibiotic therapy.
        California Med. 1957; 86: 120
        • Robertson J.A.
        Systemic moniliasis. Report of a case.
        California Med. 1956; 84: 115
        • Shurtleff D.B.
        • Peterson W.
        • Sherris J.C.
        Systemic Candida tropicalis infection treated with amphotericin.
        New England J. Med. 1963; 269: 1112
        • Barrett B.
        • Volwiler W.
        • Kirby W.M.M.
        • Jensen C.R.
        Fatal systemic moniliasis following pancreatitis.
        Arch. Int. Med. 1957; 99: 209
        • Boyd J.F.
        • Chappell A.G.
        Fatal mycetosis due to Candida albicans after combined steroid and antibiotic therapy.
        Lancet. 1961; 2: 19
        • French G.
        • Shenoi V.
        Disseminated moniliasis with demonstration of the organism in the blood.
        Canad. M. A. J. 1954; 71: 238
        • Schaberg A.
        • Hildes J.A.
        • Wilt J.C.
        Disseminated candidiasis.
        Arch. Int. Med. 1955; 95: 112
        • Skobel P.
        • Jorke D.
        • Schabenski G.
        Akute generalisierte Mykose: Sepsis durch Candida pseudotropicalis.
        München med. Wchnschr. 1955; 97: 194
        • Louria D.B.
        • Stiff D.P.
        • Bennett B.
        Disseminated moniliasis in the adult.
        Medicine. 1962; 41 (Cited in [165].): 307
        • Higuchi K.
        • Iwasaki H.
        Systemic candidiasis complicated with leukaemia.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 176
        • Yaffe S.A.
        Superinfection and systemic moniliasis.
        Canad. M. A. J. 1958; 78: 944
        • Rankin N.E.
        Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy.
        Brit. M. J. 1953; 1: 918
        • Merchant R.K.
        • Louria D.B.
        • Geisler P.H.
        • Edgcomb J.H.
        • Utz J.P.
        Fungal endocarditis: review of the literature and report of three cases.
        Ann. Int. Med. 1958; 48: 242
        • Pearl M.A.
        • Sidransky H.
        Candida endocarditis. Two new cases, with a review of twelve cases previously reported.
        Am. Heart J. 1960; 6: 345
        • Koelle W.A.
        • Pastor B.H.
        Candida albicans endocarditis after aortic valvulotomy.
        New England J. Med. 1956; 255: 997
        • Persellin R.H.
        • Haring O.M.
        • Lewis F.J.
        Fungal endocarditis following cardiac surgery.
        Ann. Int. Med. 1961; 54: 127
        • Sanger P.W.
        • Taylor F.H.
        • Robicsek F.
        • Germuth F.
        • Senterfit L.
        • McKinnon G.
        Candida infection as a complication of heart surgery.
        J.A.M.A. 1962; 181: 88
        • Utz J.P.
        • Roberts W.C.
        Candida endocarditis: an emerging peril in cardiovascular surgery.
        Ann. Int. Med. 1961; 54: 1058
        • Evans W.E.D.
        • Winner H.I.
        The histogenesis of the lesions in experimental moniliasis in rabbits.
        J. Path. & Bact. 1954; 67: 531
        • Hurley R.
        • Winner H.I.
        The pathogenicity of Candida tropicalis.
        J. Path. & Bact. 1962; 84: 33
        • Diaz J.J.
        Moniliasis urinaria tras la terapeutica con antibioticos.
        Rev. clin. espãn. 1953; 48: 97
        • Davis J.B.
        • Whitaker J.D.
        • Ding L.K.
        • Kiefer J.H.
        Disseminated, fatal, post-partum candidiasis with renal suppuration: case report.
        J. Urol. 1956; 75: 930
        • Goldman H.J.
        • Littman M.L.
        • Oppenheimer G.D.
        • Glickman S.I.
        Monilial cystitis—effective treatment with instillations of amphotericin B.
        J.A.M.A. 1960; 174: 359
        • Albers D.D.
        Monilial infection of the kidney: case reports.
        J. Urol. 1953; 69: 32
        • Gillam J.F.E.
        • Wadelton D.H.
        A case of renal moniliasis.
        Brit. M. J. 1958; 1: 985
      6. Editorial. Moniliasis in the urinary tract.
        J.A.M.A. 1960; 174: 405
        • Engelhard C.F.
        Candida albicans infection in a child.
        J. Pediat. 1948; 32: 404
        • Guze L.B.
        • Haley L.D.
        Fungus infections of the urinary tract.
        Yale J. Biol. & Med. 1958; 30: 292
        • Stenderup A.
        • Pedersen G.T.
        Yeasts of human origin.
        Acta path. et microbiol. scandinav. 1962; 54: 462
        • Beckmann A.J.
        • Navarro J.E.
        Pneumonia complicating oral thrush treated with mycostatin, a new antifungal antibiotic.
        J. Pediat. 1955; 46: 587
        • Findlay Jr., C.W.
        • Kleinfeld G.
        Monilial empyema treated successfully with intrapleural instillations of amphotericin B.
        J. Thoracic & Cardiooasc. Surg. 1959; 38: 244
        • McKendrick G.D.W.
        • Medlock J.M.
        Pulmonary moniliasis treated with nystatin aerosol.
        Lancet. 1958; 1: 621
        • Mukherjee B.B.
        Bronchopulrnonary moniliasis.
        J. Indian M. A. 1958; 31: 363
        • Osimani J.J.
        Un caso de moniliasis bronquial tratado con nistatin.
        An. Fac. med. Montevideo. 1956; 41: 309
        • Paquette J.P.
        Mycose pulmonaire et infection pulmonaire à staphylocoques pyogènes.
        Union med. Canada. 1960; 89: 1164
        • Romano A.
        • Casuccio L.
        • Martinez R.
        Azione della nistatina somministrata per via aerosolica in soggetti portatori di Candida A. nell'albero bronchiale.
        Boll. Soc. ital. biol. sper. 1958; 34: 923
        • Sahni P.S.
        Pulmonary moniliasis.
        J. Pediat. 1957; 50: 484
        • Viola M.S.
        • Roda A.P.
        Bronchopulrnonary moniliasis with a case report.
        J. Philippine M.A. 1956; 32: 347
        • Kurotchkin T.J.
        • Lim C.E.
        Experimental bronchomoniliasis in sensitized rabbits.
        in: Proc. Soc. Exper. Biol. & Med.31. 1933: 332
        • Urso B.
        Nuovo contributo alla bronchomoniliasi sperimental.
        Arch. ital. sc. med. trop. 1950; 31: 77
        • Aoyama S.
        • Ata S.
        Studies on candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 115-121
        • Felisati D.
        • Bastianini L.
        • De Mitri T.
        Antibiotics and Candida albicans given by endobronchial route.
        Antibiotics & Chemother. 1959; 9: 744
        • Castellani A.
        Reports.
        Ceylon M. Rep. 1904–1914;
        • Winner H.I.
        • Hurley R.
        Candida Albicans.
        J. & A. Churchill Ltd, London W.11964 (Cited in [10].)
        • Haley L.D.
        • McCabe A.
        A mycologic study of seventy-one autopsies.
        Am. J. Clin. Path. 1950; 20: 35
        • Bratlund H.
        • Holten C.
        Moniliasis of the mucous membranes and lungs as a complication of treatment with antibiotics corticotropin arid cortisone.
        Danish M. Bull. 1954; 1: 79
        • Shrewsbury J.F.D.
        Secondary thrush of the bronchi.
        Quart. J. Med. 1936; 5: 375
        • Riddell R.W.
        • Clayton Y.M.
        Pulmonary mycoses occurring in Britain.
        Brit. J. Tubers. 1958; 52: 34
        • Charpin J.
        • Zafiropoulo A.
        • Blanc M.
        Allergies respiratoires dués à Candida albicans.
        Path. et Biol. 1960; 8: 319
        • Keeney E.L.
        Candida asthma.
        Ann. Int. Med. 1951; 34: 223
        • Keeney E.L.
        Pulmonary mycotic infections. Allergic and immunologic factors.
        California Med. 1954; 81: 367
        • Neufeld O.
        • Wallbank W.L.
        Case of Candida asthma and its management.
        J. Michigan M. Soc. 1952; 51: 1419
        • Oblath R.W.
        • Donath D.H.
        • Kerr W.J.
        Pulmonary moniliasis.
        Ann. Int. Med. 1951; 35: 97
        • Scott P.W.
        A possible case of pulmonary moniliasis.
        Am. Rev. Tuberc. 1958; 77: 329
        • Goldin M.
        • Libretti A.
        • Hoffman A.
        • Kaplan M.A.
        Studies on antibodies to yeasts in bronchial asthma.
        Ann. Allergy. 1957; 15: 119
        • Angioli G.
        • Gorecki Z.
        Combined use of nystatin and antituberculous drugs in the management of coexistent fungaltuberculous infections.
        Canad. M. A. J. 1960; 82: 1274
        • Rioux J.-A.
        • Verdier P.
        • Plane J.
        Sur la fréquence des infestations saprophytiques à Candida chez les tuberculeux pulmonaires.
        Le Poumon. 1954; 10: 101
        • Schulte H.W.
        Die lokalisierte Candidamykose in Kombination mit der Lungentuberkulose.
        Tuberkulosearzt. 1957; 11: 751
        • Schwarting V.M.
        • Skinner C.E.
        Candida in sputum of patients with tuberculosis.
        Mycopathologia (The Haag). 1949; 4: 349
        • Seuderling Y.
        • Kumlin T.
        Some aspects of pulmonary mycosis.
        Ann. med. int. Fenniae. 1951; 40: 295
        • Falkmer S.
        • Wising P.J.
        Fatal bronchopulmonary moniliasis.
        Acta med. scandinav. 1955; 151: 117
        • Floch H.
        “Moniliase” broncho-pulmonaire en Guyane française.
        Bull. Soc. path. Exot. 1952; 45: 620
        • Florange W.
        Soorpneumonie als Folge massiver Antibioticatherapie.
        Med. Klin. 1954; 49: 225
        • Smith G.M.
        • Armen R.N.
        Pulmonary moniliasis treated by brilliant green aerosol: report of a case.
        Ann. Int. Med. 1955; 43: 1302
        • Hurwitz A.
        • Yesner R.
        A report of a case of localized bronchopulmonary moniliasis successfully treated by surgery.
        J. Thoracic Surg. 1948; 17: 826
        • Rey J.C.
        • Natin I.
        Moniliasis pulmonar.
        Prensa méd. argent. 1953; 40: 2306
        • Smulewicz J.
        Über einen Fall von Moniliasis der Lungen.
        Schweiz. med. Wchnschr. 1953; 83: 702
        • Vadala A.J.
        Mycotic infection of bronchopulmonary tract.
        Ann. Otol. Rhin. & Laryng. 1940; 49: 291
        • Kostmann R.
        Moniliasis of the respiratory tract.
        Acta paediat. 1945; 32 (Cited in [9].): 520
        • Keiper T.W.
        Studies on yeastlike fungi isolated from pulmonary disease (bronchoraoniliasis).
        J. Lab. & Clin. Med. 1938; 23: 343
        • Kostmann R.
        Moniliasis of the respiratory tract.
        Acta paediat. 1945; 32 (Cited in [9].): 520
        • Browne S.G.
        Moniliasis following antibiotic therapy.
        Lancet. 1954; 1: 393
        • Pace L.
        Un caso di moniliasi settica con rara complicazione pneumonica.
        Riform. Medica. 1957; 71: 36
        • Sivertson S.E.
        • Jaeck J.L.
        Hypersensitivity angiitis of the lung. Report of a case associated with pulmonary moniliasis.
        Wisconsin M. J. 1960; 59: 197
        • Steinberg I.
        Fatal fungus infection in sarcoidosis: report of two cases treated with antibiotics and cortisone.
        Ann. Int. Med. 1958; 48: 1359
        • Wilson J.W.
        Therapy of systemic fungous infections in 1961.
        Arch. Int. Med. 1961; 108: 292
        • Sarewitz A.B.
        Treatment of genitourinary moniliasis with orally administered nystatin.
        Ann. Int. Med. 1955; 42: 1187
        • Kozinn P.J.
        • Taschdjian C.L.
        • Dragutsky D.
        • Minsky A.
        Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B.
        Antibiotics Ann. 1956–1957; : 128
        • Solomon P.
        Oral moniliasis complicating combined-broad-spectrum-antibiotic and antifungal therapy.
        New England J. Med. 1961; 265: 847
        • Chamberlain C.
        • Burros H.M.
        • Borromeo V.
        Tetracycline and tetracycline-nystatirt in chronic urinary tract infections.
        Antibiotic Med. 1958; 5: 521
        • Gallaraga E.
        • Williams M.D.
        • Billow B.W.
        The clinical trial of tetracycline phosphate complex combined with nystatin in the treatment of bacterial pneumonia.
        Antibiotics Ann. 1957–1958; : 439
        • Gimble A.I.
        • Shea J.G.
        • Katz S.
        Nystatin and tetracycline in the treatment of bacterial infections.
        Antibiotics Ann. 1955–1956; : 676
        • Takahashi H.
        • Tsubura E.
        • Tanaka H.
        • Hirao F.
        Effect of oral administration of inystatin (mycostatin) and tetracycline-nystatin (Mysteclin) tablets.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 30
        • Welch H.
        A rational approach to combined antibiotic therapy.
        Antibiotic Med. & Clin. Therapy. 1956; 3: 375
        • Welch H.
        The place of nystatin in chemotherapy.
        Antibiotic Med. 1956; 2: 79